Xu W - Search Results

1

Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study.

Shi YK, Hong XN, Yang JL, Xu W, Huang HQ, Xiao XB, Zhu J, Zhou DB, Han XH, Wu JQ, Zhang MZ, Jin J, Ke XY, Li W, Wu DP, Yang SM, Du X, Jia YQ, Liu AC, Liu DH, Shen ZX, Zhang LS, James L, Hellriegel E. Shi YK, et al. Among authors: xu w. Chin Med J (Engl). 2021 May 6;134(11):1299-1309. doi: 10.1097/CM9.0000000000001463. Chin Med J (Engl). 2021. PMID: 33967195 Free PMC article. Clinical Trial.

2

Outcome of treatment with Hyper-CVAD regimen in Chinese patients with acute lymphocytic leukemia.

Xu W, Li JY, Qian SX, Wu HX, Lu H, Chen LJ, Zhang SJ, Lu RL, Sheng RL. Xu W, et al. Leuk Res. 2008 Jun;32(6):930-5. doi: 10.1016/j.leukres.2007.10.019. Epub 2007 Dec 3. Leuk Res. 2008. PMID: 18061665

3

[Comparison between efficacy and safety of rituximab plus CHOP regimen and CHOP regimen for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].

Xu W, Li JY, Zhang ZH, Qiu HX, Qian SX, Wu HX, Lu H, Sheng RL. Xu W, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):933-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18718094 Clinical Trial. Chinese.

4

[IDA-FLAG regimen in treatment of patients with refractory or relapsed acute leukemia].

Qian SX, Li JY, Wu HX, Zhang R, Hong M, Xu W, Qiu HX. Qian SX, et al. Among authors: xu w. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Apr;17(2):464-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19379589 Clinical Trial. Chinese.

5

Fcγ receptor polymorphisms and clinical efficacy of rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Zhuang Y, Xu W, Shen Y, Li J. Zhuang Y, et al. Among authors: xu w. Clin Lymphoma Myeloma Leuk. 2010 Oct;10(5):347-52. doi: 10.3816/CLML.2010.n.067. Clin Lymphoma Myeloma Leuk. 2010. PMID: 21030347 Review.

6

[Cytogenetic study of mantle cell lymphoma].

Wang DM, Fan L, Fang C, Zhu DX, Dong H, Yang H, Qiu HR, Hong M, Qiao C, Xu W, Li JY. Wang DM, et al. Among authors: xu w. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Jun;28(3):283-6. doi: 10.3760/cma.j.issn.1003-9406.2011.03.010. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011. PMID: 21644224 Chinese.

7

[Treatment of elderly indolent lymphoma].

Xu W, Miao K. Xu W, et al. Zhonghua Xue Ye Xue Za Zhi. 2014 Apr;35(4):286-7. doi: 10.3760/cma.j.issn.0253-2727.2014.04.007. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24759012 Chinese. No abstract available.

8

The significance of single nucleotide polymorphism rs2070770 in CD20 gene in Chinese patients with diffuse large B-cell lymphoma.

Zhang LN, Wang L, Fang C, Zou ZJ, Fan L, Zhang R, Young KH, Li JY, Xu W. Zhang LN, et al. Among authors: xu w. Leuk Lymphoma. 2015 Mar;56(3):676-81. doi: 10.3109/10428194.2014.927455. Epub 2014 Jul 17. Leuk Lymphoma. 2015. PMID: 24898664

9

[FcγRIII a polymorphisms and efficacy of Rituximab combined chemotherapy for diffuse large B-cell lymphoma in Chinese patients].

Zhuang Y, Qiao C, Yang G, Shen Y, Qian X, Yang L, Xu W, Li J. Zhuang Y, et al. Among authors: xu w. Zhonghua Xue Ye Xue Za Zhi. 2014 Sep;35(9):816-21. doi: 10.3760/cma.j.issn.0253-2727.2014.09.007. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 25246250 Chinese.

10

[Progress of bendamustine in the treatment of B cell non-Hodgkin lymphoma].

Zhu H, Xu W, Li J. Zhu H, et al. Among authors: xu w. Zhonghua Xue Ye Xue Za Zhi. 2015 Nov;36(11):972-6. doi: 10.3760/cma.j.issn.0253-2727.2015.11.019. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 26632476 Free PMC article. Chinese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,192 results

Search Page

Filters